Search results

Selected filters:

Valuation
Analysis

Article type

Topic

Sector

Regions

Year

524 results found for your search

Sort options
19 July 2019

Alphabet is trimming down its portfolio - but only after sustained growth  

The tech giant saw a steep drop in the number of US patents granted in 2018 after having spent years building its portfolio organically and through strategic acquisitions

16 July 2019

Gilead’s unique $5.1 billion licensing deal shows the range of IP monetisation options open to biotech sector

New boss explains that the Big Pharma company will seek out “diverse and creative” asset partnerships – rather than large acquisitions – to boost its pipeline

08 July 2019

Bankrupt mobile firm's patents could hit the market soon

It wouldn't be the summer’s biggest auction, but Gionee’s China-heavy smartphone patent portfolio could draw interest from Chinese operating companies and NPEs focused on the market

05 July 2019

Get ready for the first CRISPR patent pool

In an exclusive interview, MPEG LA’s Kristin Neuman says that a pool is on its way despite the UCal v Broad stand-off and talks about the future of licensing in biotech’s ‘golden age’

02 July 2019

AbbVie’s Allergan play designed to mitigate Humira patent cliff

The $63 billion purchase is designed to mitigate the effects of losing the exclusive rights to the world’s best selling drug

29 June 2019

Faraday Future’s patent portfolio may be small, but it packs a punch

The struggling electric vehicle start-up has invested significantly in building its assets, and while it trails behind competitors it has a number of holdings in valuable areas which may come in handy

28 June 2019

Politics, money could temper Chinese interest in Intel auction

A few years ago, it might have been different. But political, legal and economic uncertainty may combine to keep firms like Huawei and ZTE out of the running for Intel’s wireless IP

22 June 2019

United Technologies to become aerospace and defence behemoth with Raytheon merger

The Farmington-based company has ramped up its own patent activity, and the proposed deal will expand its technologies and R&D capabilities to compete with the likes of Boeing  

13 June 2019

How Apple uses patents to win

The iPhone giant’s portfolio is at the heart of the defence it plays when the subject of an assertion – and analysis shows that much of it has been acquired rather than grown organically

13 June 2019

Huawei’s $1 billion Verizon demand: politics or profit?

Ongoing royalty negotiations are revealed after US network operator reportedly notifies government. Why the conflict, which follows a 2016 dispute with T-Mobile, may alarm Nokia and Ericsson

07 June 2019

Roche trumps rivals with strongest biotech patent portfolio

Trailing behind the Swiss giant are DowDuPont and Bayer, both of which have seen a drop in the value of their holdings

04 June 2019

IP3 deals platform makes key rule change to drum up more seller interest

Patent owners will not be required to take assets off the market after making submissions; this year's programme also features new sector focus areas

17 May 2019

The pledge that may reduce Tesla’s value as it seeks additional funds

In 2014, Elon Musk vowed not to sue anyone for patent infringement if they used the company’s technology in “good faith”. Five years later and that may not look to be such a great idea

09 May 2019

Inside the IBM patent factory

Although it has been the number one recipient of US grants every year this century and before, Big Blue’s abandonment strategy means its portfolio is not America’s biggest. It has also been quietly recalibrating its holdings

07 May 2019

Faraday Future seeks lifeline from $1.25 billion IP valuation

Cash-strapped electric vehicle start-up hopes to attract much-needed funding after Houlihan Lokey estimate of the value of its portfolio, which includes tech, patents and trademarks